| NDC Code | 61755-019-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-019-01) / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-019-00) |
|---|
| Product NDC | 61755-019 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Inmazeb |
|---|
| Non-Proprietary Name | Atoltivimab, Maftivimab, And Odesivimab-ebgn |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20210729 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761169 |
|---|
| Manufacturer | Regeneron Pharmaceuticals, Inc. |
|---|
| Substance Name | ATOLTIVIMAB; MAFTIVIMAB; ODESIVIMAB |
|---|
| Strength | 483.3; 483.3; 483.3 |
|---|
| Strength Unit | mg/14.5mL; mg/14.5mL; mg/14.5mL |
|---|